Effectiveness of Pfizer-BioNTech COVID-19 mRNA vaccine against severe illness in the elderly in Finland (RWE_COVID19_2023)

First published 10/12/2024

Last updated 29/04/2025

EU PAS number:

EUPAS1000000376

Study

Ongoing

Download as PDF

Documents

Study protocol

No information provided.

Study results

No information provided.

Study report

No information provided.

ENCePP Seal

The use of the ENCePP Seal has been discontinued since February 2025. The ENCePP Seal fields are retained in the display mode for transparency but are no longer maintained.

No information provided.

Effectiveness of Pfizer-BioNTech COVID-19 mRNA vaccine against severe illness in the elderly in Finland (RWE_COVID19_2023)

Secondary tabs

Share this page